Piper Jaffray Upgrades Pacira Pharmaceuticals (PCRX) to Overweight
Tweet Send to a Friend
Piper Jaffray upgraded Pacira Pharmaceuticals (NASDAQ: PCRX) from Neutral to Overweight ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
